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In current usage ‘concussion’ describes a clinical presentation, but does not identify the 16 
underlying pathological process and therefore cannot be considered a true diagnosis. 17 
However, mounting evidence indicates diffuse axonal injury as a likely pathological 18 




Although more than two million individuals experience a concussion in the U.S. each year1, the 23 
condition has only burst into the spotlight in the past decade, with numerous headline news 24 
stories and even a Hollywood film. Concussion is often regarded as a form of mild traumatic 25 
brain injury (TBI); however, there is nothing ‘mild’ about this condition for many individuals. 26 
Indeed, more than 15% of individuals with concussion go on to experience persisting 27 
neurocognitive dysfunction2. Furthermore, a history of exposure to multiple concussions and 28 
head impacts, for example through participation in contact sports, has been linked to an 29 
increased risk of a number of neurodegenerative conditions3, including chronic traumatic 30 
encephalopathy3.  31 
 32 
The Oxford English Dictionary defines diagnosis as “the identification of the nature of an illness 33 
or other problem by examination of the symptoms”. Therefore, as the current concept of 34 
‘concussion’ does not encompass the “nature” of the illness with respect to an underlying 35 
pathological process, concussion should not be considered a true diagnosis. Indeed, the 36 
current, purely descriptive, use of the term concussion is arguably no more sophisticated than 37 
the old use of the term ‘consumption’ to describe the once mysterious condition that we now 38 
know to be caused by mycobacterium tuberculosis. Nonetheless, mounting evidence suggests 39 
 
 2 
that the symptoms of concussion reflect structural and physiological disruption of brain 40 
networks. In particular, mechanical damage to axons throughout the white matter, known as 41 
diffuse axonal injury (DAI), is increasingly acknowledged as a primary contributor to both the 42 
short-term and long-term clinical manifestations of concussion4,5. Therefore, the time is right to 43 
acknowledge the contribution of this pathology in order to improve approaches to concussion 44 
diagnosis and management. 45 
 46 
DAI was first observed over 60 years ago when varicose swellings along white matter axons 47 
were detected in post-mortem brain tissue from individuals with moderate and severe TBI4,5. 48 
Subsequently, the unique biomechanical origin of DAI was revealed by use of preclinical models 49 
of TBI, in which immediate loss of consciousness and persisting coma were shown to be 50 
dependent on the rapid deformation of brain tissue caused by rotational acceleration of the 51 
head4,5. In these models, injury severity and the durations of loss of consciousness and coma 52 
directly correlated with the extent of axonal pathology identified in tissue preparations. Given 53 
that similar, albeit milder, biomechanical forces have been implicated in the induction of 54 
concussion, interest in examining the presence and importance of DAI in this condition has 55 
been rapidly growing.  56 
 57 
In 1994, post-mortem examination of the brains of five mostly elderly individuals who died 58 
shortly after a concussion, but from other causes, revealed surprisingly extensive axonal 59 
pathology throughout the white matter in the absence of other neuropathological changes6. 60 
More recently, DAI was identified as the predominant pathology in a pig model of head 61 
rotational acceleration that was designed to mimic the biomechanics of human concussion4,5. 62 
Importantly, in this model, immediate loss of consciousness was associated with the presence 63 
of axonal pathology in the brainstem.  64 
 65 
Under the unique mechanical loading conditions of concussion, axons have been found to be 66 
selectively vulnerable to damage owing, in part, to their highly anisotropic organization and 67 
viscoelastic properties. During normal daily activities, axons tolerate stretching of up to twice 68 
their resting length; however, under the rapid or ‘dynamic’ deformation caused by rotational 69 
acceleration (Fig. 1a, adapted with permission5), the axon becomes stiffer and more brittle, 70 
making it more prone to injury4,5. This high rate of stretching results in immediate mechanical 71 
damage to the axonal cytoskeleton, loss of ionic homeostasis and metabolic crisis4,5. In turn, 72 
axonal transport is interrupted, leading to accumulation of proteins in swellings, which is 73 
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followed by proteolysis and, eventually, axonal degeneration4,5,7 (Fig. 1b, adapted with 74 
permission7). However, even in severe TBI, this pathological sequence affects only a minority of 75 
axons4. The remainder continue to look structurally normal, but might nonetheless be 76 
dysfunctional. This collective axonal dysfunction can induce immediate and persisting disruption 77 
of signaling across brain networks, resulting in loss of consciousness and/or alterations in 78 
cognitive status, such as decreased processing speed2.  79 
 80 
Perhaps the most extensive body of evidence supporting DAI as a key substrate of concussion 81 
is from advanced neuroimaging studies. The microscopic nature of the axonal swellings renders 82 
DAI nearly invisible to conventional brain imaging examinations. However, in a small proportion 83 
of individuals with concussion, subtle white matter changes can be observed with standard MRI, 84 
leading to a tentative diagnosis of DAI4,5. These observations precipitated extensive efforts to 85 
use enhanced neuroimaging to identify this otherwise ‘stealth’ pathology. For over 20 years, 86 
multiple advanced MRI techniques, such as diffusion tensor imaging, have consistently 87 
identified white matter changes after concussion in animal models4,5 and in humans8. For the 88 
former, histopathological examination indicated that these MRI signal changes corresponded 89 
with regions of axonal pathology4. However, despite so many years of success and refinement, 90 
none of these advanced neuroimaging techniques have been included in routine assessment of 91 
patients with suspected concussion, owing, in part, to the highly sophisticated nature of the 92 
techniques, the length of time needed for image processing and the difficulty in calibration 93 
between MRI scanners. 94 
 95 
Blood biomarker studies have also implicated DAI as an underlying pathology in concussion. 96 
Specifically, the blood concentrations of axonal proteins — including calpain-cleaved αII-97 
spectrin N-terminal fragment (SNTF) and the microtubule-associated proteins tau and 98 
neurofilament light chain — were higher in samples from individuals with symptoms of 99 
concussion than in pre-injury samples or samples from healthy individuals9,10. In another study, 100 
elevated SNTF levels measured in plasma samples taken within 24h of injury identified a subset 101 
of concussion patients with persisting neurocognitive dysfunction when assessed at 3 102 
months9,10. Of note, histology studies in moderate to severe TBI in humans and in mild TBI in 103 
swine have now identified damaged axons as the source of this SNTF, tau and neurofilament 104 
light10. Thus, the identification of axonal proteins in the serum serves as a marker of axon lysis 105 
and degeneration. As damaged axons in the brain do not regenerate, these observations 106 
indicate that permanent brain damage occurs in some individuals with concussion. These 107 
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findings also raise the likelihood that concussion involves a range of axonal pathophysiology, 108 
including reversible changes (such as ionic imbalance), the presence of intact but dysfunctional 109 
axons, and axon degeneration, which might be associated with persisting and potentially 110 
progressive symptoms.  111 
 112 
The identification of mycobacterium tuberculosis in the late 19th century revealed the source of 113 
‘consumption’ and led to a true diagnostic entity and, eventually, treatment. In much the same 114 
way, now is the time for the term ‘concussion’ to embody the nature of the disorder. This 115 
improvement is now possible as a result of the progress made in the past decade, from 116 
characterization of the pathological processes underlying the injury through to advances in 117 
diagnostic neuroimaging and blood biomarker studies. Ideally, this new approach to diagnosis 118 
will include broad implementation of non-invasive techniques to identify individuals at risk of 119 
persisting neurocognitive dysfunction, thus improving clinical management and providing a 120 
rational basis for selective enrollment in clinical trials. Furthermore, advanced imaging and fluid 121 
biomarker approaches will be important to follow potential long-term changes that might lead to 122 
neurodegenerative disorders like chronic traumatic encephalopathy, which could be driven by 123 
progressive axonal pathology4,5. We anticipate that other pathological processes, such as 124 
disruption of the blood–brain barrier and inflammation4, will be shown to have a role in 125 
concussion symptoms; however, for now, objective identification of degenerative DAI and its 126 
aftermath can provide a framework for operational diagnostic criteria that can be refined over 127 
time. Indeed, based on the rate of development, we anticipate that blood biomarker techniques 128 
that identify degenerative DAI will be ready for broad application in the near future. Therefore, 129 
now is the time to transform the diagnosis of concussion.  130 
 131 
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Figure 1: Diffuse axonal injury in concussion a | The principal mechanical trigger of 169 
traumatic brain injury is head rotational acceleration, which induces dynamic deformation of 170 
brain tissue. b | Axonal microtubules (blue and red) are ruptured at the moment of head impact, 171 
leading to interruption of protein transport, accumulation of cargos proteins (green) and the 172 
development of periodic varicose swelling along white matter axons. Part a adapted from ref5, 173 
part b adapted from ref7. 174 
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